Clinical Trial

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Study acronym: BLINDER
Recruiting
View on ClinicalTrials.gov →
Summary
This retrospective study is aimed at evaluating the levels of circulating anti-nephrin autoantibodies in patients with INS, including those with MCD/FSGS and in patients who have experienced relapse of FSGS post-transplant, compared to those of a control group of patients with nephrotic syndrome due to primary membranous nephropathy (MN).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-03-27; most recent amendment 2025-08-27.
Status change: Active, Not Recruiting → Recruiting 2025-08-27
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-05-08
Trial Details
NCT Number NCT06334692
Lead Sponsor Mario Negri Institute for Pharmacological Research
Conditions Nephrotic Syndrome
Enrollment 100 participants
Start Date 2024-03-19
Primary Completion 2028-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-04